Bcl-2/Bcl-xL inhibition predominantly synergistically enhances the anti-neoplastic activity of a low-dose CUSP9 repurposed drug regime against glioblastoma

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Halatsch, Marc-Eric

Kast, Richard Eric

Dwucet, Annika

Hlavac, Michal

Heiland, Tim

et al.

Institutions

UKU. Klinik für Neurologie
UKU. Klinik für Neurochirurgie
UKU. Klinik für Kinder- und Jugendmedizin

Published in

British journal of clinical pharmacology ; 176 (2019), 18. - S. 3681-3694. - ISSN 0306-5251. - eISSN 1365-2125

Link to publication

https://dx.doi.org/10.1111/bph.14773

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record